Mo W - Search Results

1

Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Ding Y, Mo W, Xie X, Wang O, He X, Zhao S, Gu X, Liang C, Qin C, Ding K, Yang H, Ding X. Ding Y, et al. Among authors: mo w. Oncol Res Treat. 2023;46(7-8):303-311. doi: 10.1159/000531492. Epub 2023 Jun 9. Oncol Res Treat. 2023. PMID: 37302393 Clinical Trial.

2

A support vector machine model for predicting non-sentinel lymph node status in patients with sentinel lymph node positive breast cancer.

Ding X, Xie S, Chen J, Mo W, Yang H. Ding X, et al. Among authors: mo w. Tumour Biol. 2013 Jun;34(3):1547-52. doi: 10.1007/s13277-013-0683-5. Epub 2013 Feb 10. Tumour Biol. 2013. PMID: 23397544

3

Serum tissue polypeptide-specific antigen is an independent predictor in breast cancer.

Xie S, Ding X, Mo W, Chen J. Xie S, et al. Among authors: mo w. Acta Histochem. 2014 Mar;116(2):372-6. doi: 10.1016/j.acthis.2013.09.001. Epub 2013 Oct 18. Acta Histochem. 2014. PMID: 24144486

4

Expression of integrin-binding protein Nischarin in metastatic breast cancer.

Chen J, Feng WL, Mo WJ, Ding XW, Xie SN. Chen J, et al. Mol Med Rep. 2015 Jul;12(1):77-82. doi: 10.3892/mmr.2015.3373. Epub 2015 Feb 18. Mol Med Rep. 2015. PMID: 25695373 Free PMC article.

5

Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer.

Ding X, Zhang Y, Yang H, Mao W, Chen B, Yang S, Ding X, Zou D, Mo W, He X, Zhang X. Ding X, et al. Among authors: mo w. Oncotarget. 2017 Apr 21;8(35):58210-58221. doi: 10.18632/oncotarget.17356. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938549 Free PMC article.

6

Associations between folate metabolism enzyme polymorphisms and breast cancer: A meta-analysis.

Mo W, Ding Y, Zheng Y, Zou D, Ding X. Mo W, et al. Breast J. 2020 Mar;26(3):484-487. doi: 10.1111/tbj.13527. Epub 2019 Sep 23. Breast J. 2020. PMID: 31549463

7

Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China.

Ding Y, Ding K, Yu K, Zou D, Yang H, He X, Mo W, Yu X, Ding X. Ding Y, et al. Among authors: mo w. Oncol Lett. 2019 Dec;18(6):6690-6696. doi: 10.3892/ol.2019.11033. Epub 2019 Nov 1. Oncol Lett. 2019. PMID: 31807179 Free PMC article.

8

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.

Ding Y, Ding K, Qian H, Yu X, Zou D, Yang H, Mo W, He X, Zhang F, Qin C, Zheng Y, Ding X. Ding Y, et al. Among authors: mo w. PLoS One. 2020 Apr 16;15(4):e0231895. doi: 10.1371/journal.pone.0231895. eCollection 2020. PLoS One. 2020. PMID: 32298374 Free PMC article.

9

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience.

Zheng Y, Ding X, Zou D, Zhang F, Qin C, Yang H, Mo W, Ding Y, Yu Y. Zheng Y, et al. Among authors: mo w. Cancer Biol Ther. 2020 Aug 2;21(8):675-687. doi: 10.1080/15384047.2020.1756707. Epub 2020 May 18. Cancer Biol Ther. 2020. PMID: 32420815 Free PMC article.

10

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.

Ding Y, Ding K, Yang H, He X, Mo W, Ding X. Ding Y, et al. Among authors: mo w. PLoS One. 2020 May 29;15(5):e0234058. doi: 10.1371/journal.pone.0234058. eCollection 2020. PLoS One. 2020. PMID: 32470093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,020 results

Search Page

Filters